Latest filing published 07 Jan 2022 for ACACIA PHARMA GROUP, €6,427. Read the official filing
This profile gathers the share dealings of Borkowski Edward in Acacia Pharma Group. Between 30 June 2021 and 29 December 2021, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 3 purchases, €18k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2022, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €6,178. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The record was last updated on 7 January 2022 with an open-market purchase (€6,427) in Acacia Pharma Group. The median gap between a trade and its publication by FSMA is 12 days. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by FSMA. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations